3-methoxytyrosine has been researched along with Restless Legs Syndrome in 1 studies
Restless Legs Syndrome: A disorder characterized by aching or burning sensations in the lower and rarely the upper extremities that occur prior to sleep or may awaken the patient from sleep.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Allen, RP | 1 |
| Connor, JR | 1 |
| Hyland, K | 1 |
| Earley, CJ | 1 |
1 other study available for 3-methoxytyrosine and Restless Legs Syndrome
| Article | Year |
|---|---|
Abnormally increased CSF 3-Ortho-methyldopa (3-OMD) in untreated restless legs syndrome (RLS) patients indicates more severe disease and possibly abnormally increased dopamine synthesis.
Topics: Adult; Aged; Biomarkers; Circadian Rhythm; Dihydroxyphenylalanine; Dopamine; Female; Humans; Linear | 2009 |